The objectives are two-fold: 1) to determine the role of Ca2+-activated, phospholipid-dependent protein kinase (PKC, a receptor for TPA) in mouse skin tumor promotion; and 2) to analyze the mechanism by which PKC activation transduces signal(s) for ornithine decarboxylase (ODS) induction, a biochemical change associated with skin-tumor promotion by TPA. Recently, we found that diacylglycerol (DG), an activator of PKC, and phospholipase C (which releases DG from membrane phospholipids) induced ODC activity which correlated with the amount of ODC mRNA in cultured newborn mouse epidermal cells. Also, palmitoylcarnitine (PC), an inhibitor of PKC, inhibited TPA-induced ODC and ODC mRNA and tumor promotion by TPA in intact mouse skin. These preliminary results have led us to hypothesize that PKC activation is an initial event in ODC-gene transcription and skin tumor promotion by TPA and that TPA-increased ODC mRNA is mediated by PKC-dependent phosphorylation, directly or indirectly, of nuclear proteins. Specifically, we plan to seek answers to the following questions: 1) Is PKC activation involved in tumor promotion? In this we plan to a) determine the tumor promoting activity of agents (e.g., diacylglycerols) which activate PKC; b) determine whether the agents which inhibit PKC (e.g., PC) also proportionally inhibit skin tumor promotion by TPA; c) determine whether PKC-dependent phosphorylation of endogenous epidermal proteins correlates to the degree of tumor promotion susceptibility in B2S, SENCAR, and CD-1 mice. 2) Does PKC affect ODC-gene transcription in cultured newborn mouse epidermal cells? 3) What are the physiological protein substrates (targets) for PKC? 4) Does PKC-dependent phosphorylation of nuclear proteins affect ODC-gene transcription? Tumor induction experiments will be performed by the initiation-promotion protocol. The rate of ODC-gene transcription will be determined by measurement of incorporation of (3H)uridine into ODC mRNA by DNA-excess filter hybridization. PKC-dependent phosphorylated proteins will be separated by 2-D gel electrophoresis and then characterized by peptide mapping and phosphoamino acid analysis. The role of PKC-mediated phosphorylated chromosomal proteins in regulating ODC-gene transcription will be directly examined by determining template activity of reconstituted chromatin. This study will permit an evaluation of the role of PKC in ODC induction and tumor promotion by TPA.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA035368-05
Application #
3172956
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1983-07-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hafeez, Bilal Bin; Meske, Louise; Singh, Ashok et al. (2016) Tissue-specific conditional PKC? knockout mice: a model to precisely reveal PKC? functional role in initiation, promotion and progression of cancer. Oncotarget 7:33069-80
Singh, Anupama; Singh, Ashok; Sand, Jordan M et al. (2015) Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomas. J Invest Dermatol 135:1098-1107
Hafeez, Bilal Bin; Jamal, Mohammad Sarwar; Fischer, Joseph W et al. (2012) Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-?B signaling pathways. Int J Cancer 131:2175-86
Sand, Jordan M; Bin Hafeez, Bilal; Jamal, Mohammad Sarwar et al. (2012) Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas. Carcinogenesis 33:184-90
Sand, Jordan Marshall; Bin Hafeez, Bilal; Aziz, Moammir Hasan et al. (2012) Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cýý with Stat3 involve integration with ERK1/2. Mol Carcinog 51:291-302
Hafeez, Bilal Bin; Zhong, Weixiong; Weichert, Jamey et al. (2011) Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Cancer Res 71:2318-27
Aziz, M H; Hafeez, B B; Sand, J M et al. (2010) Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 29:3100-9
Sand, Jordan M; Aziz, Moammir H; Dreckschmidt, Nancy E et al. (2010) PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas. J Invest Dermatol 130:270-7
Aziz, Moammir Hasan; Sundling, Kaitlin Elizabeth; Dreckschmidt, Nancy Ellen et al. (2009) Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis. J Invest Dermatol 129:2011-21
Aziz, Moammir H; Dreckschmidt, Nancy E; Verma, Ajit K (2008) Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res 68:9024-32

Showing the most recent 10 out of 47 publications